Gerald Sewack
Direktor/Vorstandsmitglied bei Tidal Therapeutics, Inc.
Aktive Positionen von Gerald Sewack
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Tidal Therapeutics, Inc.
 Tidal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Tidal Therapeutics, Inc. is a preclinical biotech company based in Quincy, MA. Tidal Therapeutics, Inc. focuses on developing nanoparticles that deliver to reprogram immune cells inside the body, with applications in oncology and immune diseases. Ulrik B. Nielsen has been the CEO of the company since 2018. Tidal Therapeutics was acquired by Sanofi on April 09, 2021 for $470 million. | Direktor/Vorstandsmitglied | - | - |
| Summation Bio, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Gerald Sewack
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Tidal Therapeutics, Inc.
Tidal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Tidal Therapeutics, Inc. is a preclinical biotech company based in Quincy, MA. Tidal Therapeutics, Inc. focuses on developing nanoparticles that deliver to reprogram immune cells inside the body, with applications in oncology and immune diseases. Ulrik B. Nielsen has been the CEO of the company since 2018. Tidal Therapeutics was acquired by Sanofi on April 09, 2021 for $470 million. | Commercial Services |
| Summation Bio, Inc. |
- Börse
- Insiders
- Gerald Sewack
- Erfahrung
